Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) - a case series.
Pediatr Hematol Oncol
; 38(7): 663-668, 2021 Oct.
Article
in English
| MEDLINE | ID: covidwho-1216504
ABSTRACT
Patients with coronavirus disease 2019 (COVID-19) from novel coronavirus (SARS-CoV-2) infection may present with immune thrombocytopenia (ITP). Multisystem inflammatory syndrome in children (MIS-C) is a serious complication of SARS-CoV-2 causing systemic organ dysfunction. This case series presents the first reported cases of patients who developed ITP following MIS-C, while completing corticosteroid tapers. These patients responded to standard of care therapies for ITP and had appropriate platelet count recovery. We emphasize the importance of careful monitoring of those recovering from COVID-19 or MIS-C, to proactively identify clinical and laboratory abnormalities, in addition to long-term cardiovascular sequelae.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Purpura, Thrombocytopenic, Idiopathic
/
Systemic Inflammatory Response Syndrome
/
COVID-19
Type of study:
Case report
/
Prognostic study
Topics:
Long Covid
Limits:
Child
/
Humans
/
Infant
/
Male
Language:
English
Journal:
Pediatr Hematol Oncol
Journal subject:
Hematology
/
Neoplasms
/
Pediatrics
Year:
2021
Document Type:
Article
Affiliation country:
08880018.2021.1917737
Similar
MEDLINE
...
LILACS
LIS